WELLS FARGO & COMPANY/MN

Position in DRTS — Alpha Tau Medical Ltd.

CIK 72971 SAN FRANCISCO, CA

Position in DRTS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$348,551

+$232,226 QoQ

Shares Held

49,300

+109.8% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. DRTS ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,995	$332,670,066
2	ALNY	Alnylam Pharmaceuticals, Inc.	342,763	$113,409,991
3	REGN	Regeneron Pharmaceuticals, Inc.	142,021	$109,731,102
4	HALO	Halozyme Therapeutics, Inc.	1,535,737	$99,254,679
5	INSM	INSMED Inc	597,384	$97,684,229
6	ASND	Ascendis Pharma A/S	154,199	$35,269,936
7	EXEL	Exelixis, Inc.	687,304	$29,478,466
8	ARGX	Argenx SE	38,104	$27,825,444

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$348,551	49,300	+109.8%	Shares	Defined	2026-05-11
2025-12-31	$116,325	23,500	+291.7%	Shares	Defined	2026-02-13
2025-09-30	$27,060	6,000	+140.0%	Shares	Defined	2025-11-13
2025-06-30	$7,800	2,500	-76.3%	Shares	Defined	2025-08-14
2024-03-31	$31,140	10,556	-2.3%	Shares	Defined	2024-05-10
2023-12-31	$32,526	10,806	0.0%	Shares	Defined	2024-02-09
2023-09-30	$40,954	10,806	0.0%	Shares	Defined	2023-11-13
2023-06-30	$47,222	10,806	0.0%	Shares	Defined	2023-08-15
2023-03-31	$31,013	10,806	0.0%	Shares	Defined	2023-05-12
2022-12-31	$34,363	10,806	0.0%	Shares	Defined	2023-02-13
2022-09-30	$63,107	10,806	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.